Semnur Pharmaceuticals, Inc.
SMNRW- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001913577
No open-market purchases or sales by Semnur Pharmaceuticals, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Other share classesSMNR
13F holders, Q2 2024
Institutional positions in Semnur Pharmaceuticals, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 20
- −4 vs. Q1 2024
- Shares held
- 5.87M
- −861.7K (−12.8%) vs. Q1 2024
- Total value
- $107.8K
- −$166.5K (−60.7%) vs. Q1 2024
- New holders
- 0
- 1 more added
- Sold out
- 4
- 3 more reduced
1 institution that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SMNRW on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 3 | $59.8K |
| Q1 2025 | 19 | $319.8K |
| Q4 2024 | 19 | $213.6K |
| Q3 2024 | 22 | $343.3K |
| Q2 2024 | 20 | $107.8K |
| Q1 2024 | 25 | $279.6K |
| Q4 2023 | 28 | $321.3K |
| Q3 2023 | 29 | $435.8K |
| Q2 2023 | 27 | $381.8K |
| Q1 2023 | 28 | $421.2K |
| Q4 2022 | 25 | $244.2K |
| Q3 2022 | 25 | $486.1K |
| Q2 2022 | 13 | $440.0K |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Semnur Pharmaceuticals, Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Schonfeld Strategic Advisors LLC | 20,000 | $400 | 0.00% | 00.0% | Unchanged |
| III Capital Management | 41,184 | $667 | 0.00% | 00.0% | Unchanged |
| Cable Car Capital LLC | 45,000 | $900 | 0.00% | 00.0% | Unchanged |
| Yakira Capital Management, Inc. | 95,000 | $1.90K | 0.00% | 00.0% | Unchanged |
| Clear Street LLC | 129,900 | $2.60K | 0.00% | −50,251−27.9% | Reduced |
| Periscope Capital Inc. | 149,500 | $2.99K | 0.00% | −50,000−25.1% | Reduced |
| Rivernorth Capital Management, LLC | 154,800 | $3.10K | 0.00% | 00.0% | Unchanged |
| Wolverine Asset Management LLC | 162,419 | $3.25K | 0.00% | 00.0% | Unchanged |
| Whitebox Advisors LLC | 200,000 | $4.00K | 0.00% | 00.0% | Unchanged |
| D. E. Shaw & Co., Inc. | 225,000 | $4.72K | 0.00% | 00.0% | Unchanged |
| Arena Investors LP | 225,000 | $4.72K | 0.08% | 00.0% | Unchanged |
| Taconic Capital Advisors LP | 257,500 | $5.41K | 0.00% | 00.0% | Unchanged |
| Cowen and Company, LLC | 323,478 | $6.47K | 0.00% | +127,757+65.3% | Added |
| Saba Capital Management, L.P. | 410,000 | $6.64K | 0.00% | 00.0% | Unchanged |
| Calamos Advisors LLC | 350,000 | $7.35K | 0.00% | 00.0% | Unchanged |
| Cubist Systematic Strategies, LLC | 393,423 | $7.87K | 0.00% | 00.0% | Unchanged |
| Hudson Bay Capital Management LP | 376,821 | $7.91K | 0.00% | −20,100−5.1% | Reduced |
| Shaolin Capital Management LLC | 443,051 | $8.86K | 0.00% | 00.0% | Unchanged |
| Polar Asset Management Partners Inc. | 1,400,000 | $28.0K | 0.00% | 00.0% | Unchanged |
| Boothbay Fund Management, LLC | 470,000 | – | – | 00.0% | Unchanged |
| Context Capital Management, LLC | 0 | $0 | 0.00% | −605,000−100.0% | Sold out |
| Meteora Capital, LLC | 0 | $0 | 0.00% | −68,878−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −130−100.0% | Sold out |
| Mangrove Partners | 0 | $0 | 0.00% | −195,103−100.0% | Sold out |
| Lynwood Capital Management Inc. | – | – | – | – | Not filed |